Abstract
We consider here an extended SIR model, including several features of the recent COVID–19 outbreak: in particular the infected and recovered individuals can either be detected (+) or undetected (–) and we also integrate an intensive care unit (ICU) capacity. Our model enables a tractable quantitative analysis of the optimal policy for the control of the epidemic dynamics using both lockdown and detection intervention levers. With parametric specification based on literature on COVID–19, we investigate the sensitivities of various quantities on the optimal strategies, taking into account the subtle trade-off between the sanitary and the socio-economic cost of the pandemic, together with the limited capacity level of ICU. We identify the optimal lockdown policy as an intervention structured in 4 successive phases: First a quick and strong lockdown intervention to stop the exponential growth of the contagion; second a short transition phase to reduce the prevalence of the virus; third a long period with full ICU capacity and stable virus prevalence; finally a return to normal social interactions with disappearance of the virus. The optimal scenario hereby avoids the second wave of infection, provided the lockdown is released sufficiently slowly. We also provide optimal intervention measures with increasing ICU capacity, as well as optimization over the effort on detection of infectious and immune individuals. Whenever massive resources are introduced to detect infected individuals, the pressure on social distancing can be released, whereas the impact of detection of immune individuals reveals to be more moderate.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
R.E. and V.C.T. are partly supported by the B\'ezout Labex, funded by ANR, reference ANR-10-LABX-58. V.C.T. is also part of ANR Cadence (ANR-16-CE32-0007), by the Chair "Mod\'elisation Math\'ematique et Biodiversit\'e" of Veolia Environnement-Ecole Polytechnique-Museum National d'Histoire Naturelle-Fondation X.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The authors thank Hélène Guérin, Olivier l’Haridon, Olivier Pietquin and Gabriel Turinici for stimulating discussions and feed-backs on early versions of that work, as well as participants of the Machine Learning Paris seminar. R.E. and V.C.T. are partly supported by the Bézout Labex, funded by ANR, reference ANR-10-LABX-58. V.C.T. is also part of ANR Cadence (ANR-16-CE32–0007), by the Chair “Modélisation Mathématique et Biodiversité” of Veolia Environnement-Ecole Polytechnique-Museum National d’Histoire Naturelle-Fondation X.
Data Availability
We have only used data from other research reports or publications or found on the website of the WHO.
